Cite
HARVARD Citation
Guigay, J. et al. (2022). Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum‐based therapy: DIRECT. Cancer reports. 5 (2), p. n/a. [Online].